Back
Cellectis SA 10K Form
Buy
53
CLLS
Cellectis SA
Last Price:
$1.52
Seasonality Move:
-3.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLLS News And Ratings
See the #1 stock for the next 7 days that we like better than CLLS
CLLS Financial Statistics
Sales & Book Value
| Annual Sales: | $41.5M |
|---|---|
| Cash Flow: | $-17.6M |
| Price / Cash Flow: | 5.97 |
| Annual Sales: | $1.61 |
| Price / Book: | 1.33 |
Profitability
| EPS (TTM): | -0.61000 |
|---|---|
| Net Income (TTM): | $-60.5M |
| Gross Margin: | $32.3M |
| Return on Equity: | -49.15% |
| Return on Assets: | -15.89% |
Cellectis SA Earnings Forecast
Key Cellectis SA Financial Ratios
-
The Gross Profit Margin over the past 18 years for CLLS is 77.88%.
-
The Selling, General & Administrative Expenses for CLLS have been equal to 20.29% of Gross Profit Margin.
-
The Research & Development expenses have been 218.13% of Revenue.
-
The Net Earning history of CLLS is -88.57% of Total Revenues.
-
Per Share Earnings over the last 14 years have been positive in 7 years.
Cellectis SA Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLLS |
| CUSIP: | 15117K |
| Website: | cellectis.com |
Debt
| Debt-to-Equity Ratio: | 0.44 |
|---|---|
| Current Ratio: | 1.67 |
| Quick Ratio: | 1.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CLLS Technical Analysis vs Fundamental Analysis
Buy
53
Cellectis SA (CLLS)
is a Buy
Is Cellectis SA a Buy or a Sell?
-
Cellectis SA stock is rated a BuyThe current Cellectis SA [CLLS] share price is $1.54. The Score for CLLS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.